Author :   Rekalov D.H.

PHARMACOTHERAPY OF DISEASES OF MUSCULOSKELETAL SYSTEM IN PATIENTS WITH RISK OF COVID-19-ASSOCIATED THROMBOINFLAMMATION
Authors: Rekalov D.H. Golovach I.Yu. Kostenko V.O.  Shevchenko M.V.... №87 (1) 2022 / Review: 40
CLINICAL AND LABORATORY MARKERS ASSOCIATED WITH ATHEROSCLEROSIS OF THE COMMON CAROTID ARTERIES IN PATIENTS WITH RHEUMATOID ARTHRITIS IN COMBINATION WITH HYPERTENSION
Authors: Daniuk I.O. Rekalov D.H. Ryndina N.G. №85 (3) 2021 / Review: 23
CLINICAL CASE IN THE PRACTICE OF RHEUMATOLOGIST: MULTIPLE MYELOMA UNDER THE MASK OF POLYARTERITIS NODOSA
Authors: Rekalov D.H. Daniuk I.O. Ryndina N.G. №84 (2) 2021 / Review: 25
CLINICAL AND NEPHROPROTECTIVE ACTIVITY OF BASIC THERAPY DRUGS IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
Authors: Kulinich A.V. Rekalov D.H. Дата: 2020-02-27 / Review: 33
A CLINICAL CASE OF IGG4-ASSOCIATED RESPIRATORY DAMAGE AND THE CHOICE OF THE OPTIMAL TREATMENT STRATEGY
Authors: Rekalov D.H. Daniuk I.O. №78 (4) 2019 / Review: 19
Rhupus-syndrome in routine clinical practice of systemic lupus erythematosus
Authors: Rekalov D.H. Daniuk I.O. №77 (3) 2019 / Review: 45
Clinical case of aortic valve insufficiency in a patient with peripheral ankylosing spondylitis
Authors: Rekalov D.H. Daniuk I.O. №73 (3) 2018 / Review: 20
TO THE 70TH ANNIVERSARY OF THE CREATION OF THE EUROPEAN LEAGUE AGAINST RHEUMATISM: THE ACHIEVEMENTS OF THE RHEUMATOLOGY
Authors: Kovalenko V. Golovach I.Yu. Yaremenko O.B. Rekalov D.H.... №69 (3) 2017 / Review: 22
ENDOTHELIAL DYSFUNCTION IN PRIMARY GOUT MEN WITH HYPERTENSION SYNDROME
Authors: Fushtey I.M. Rekalov D.H. Daniuk I.O. №62 (4) 2015 / Review: 8
The balance between benefits and risks in the therapy of rheumatoid arthritis
Authors: Rekalov D.H. Kulynych A.V. Kravchenko V.I. Prytkova A.V.... №61 (3) 2015 / Review: 13
2014 EULAR Congress (Paris, 11–14 June): the review of congress materials
Authors: Kovalenko V.M. Gnilorybov A.M. Ter-Vartanіan S.Kh. Yaremenko O.B.... №58 (4) 2014 / Review: 30
NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: DIAGNOSIS AND TREATMENT
Authors: Rekalov D.H. Kulinich A.V. Sarzhevsky A.N. Prytkova A.V.... №57 (3) 2014 / Review: 12
BiologiC Drugs: WHAT’S the difference?
Authors: Kovalenko V.M. Bortkevych O.P. Rekalov D.H. Medvedchuk G.Y. №52 (2) 2013 / Review: 14
Baseline clinical and demographical status as a predictor of therapeutic interventions efficacy in patients with rheumatoid arthritis
Authors: Kovalenko V.M. Rekalov D.H. №46 (4) 2011 / Review: 10
Joints erosive and destructive changes in patients with earlier rheumatoid arthritis: approaches to the disease course prediction
Author:Rekalov D.H. №44 (2) 2011 / Review: 10

12